High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-ß-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
Clin Infect Dis
; 63(7): 954-958, 2016 10 01.
Article
em En
| MEDLINE
| ID: mdl-27313265
ABSTRACT
Resistance to the novel ß-lactam/ß-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-ß-lactamase in diverse Enterobacteriaceae species.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ceftazidima
/
Bacteriemia
/
Enterobacteriaceae
/
Infecções por Enterobacteriaceae
/
Compostos Azabicíclicos
/
Antibacterianos
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Aged
/
Child, preschool
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article